CairnSurgical, Inc.

CairnSurgical is a medical technology company focused on improving the precision of breast conserving surgery. Their flagship product, the Breast Cancer Locator™ System (BCL™), is a patient-specific, 3D-printed surgical guide designed to reduce positive margins during tumor removal. The BCL™ provides surgeons with detailed information about tumor size, shape, and location, enabling more accurate excision and minimizing the need for re-excision surgeries.

CairnSurgical is currently conducting clinical trials in both the United States and Europe to validate the effectiveness of the BCL™ System. The company has secured significant funding to support the completion of these trials and the implementation of a limited commercial launch in select European markets. With its innovative approach and strong clinical data, CairnSurgical aims to revolutionize breast cancer surgery, improving patient outcomes and reducing healthcare costs.

CairnSurgical is a medical technology company dedicated to improving the precision of breast cancer surgery. Their mission is to develop and commercialize innovative, patient-specific tools that enable surgeons to accurately locate and remove tumors during breast-conserving surgery, ultimately reducing the need for re-excision and improving both patient outcomes and healthcare economics.

CairnSurgical fosters a collaborative and innovative culture that is driven by a shared commitment to improving breast cancer surgery outcomes. They emphasize precision and patient-centricity, recognizing the unique challenges faced by both patients and surgeons. The company attracts individuals passionate about medical technology and committed to developing solutions that enhance the surgical experience and improve patient well-being.